Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | 9L944 | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 9K2MA | — |
Multiple vaccines given/received 3rd dose in 2023; Multiple vaccines given/received 4th dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 70-year-old male patient who received Herpes zoster (Shingrix) (batch number 9L944, expiry date 30-MAR-2027) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) (batch number 9K2MA) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2021 with batch number PF454) and Shingrix (received 2nd dose in 2022 with batch number NR2X5). On 27-MAR-2025, the patient received the 4th dose of Shingrix. On an unknown date, the patient received the 3rd dose of Shingrix. On 27-MAR-2025, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Multiple vaccines given/received 4th dose). On an unknown date, the patient experienced extra dose administered (Verbatim: Multiple vaccines given/received 3rd dose in 2023). The outcome of the extra dose administered and extra dose administered were not applicable. Additional Information: GSK Receipt Date: 27-MAR-2025 The pharmacist request information about the administration of Shingrix every year, specifying that they wish to receive recommendations on how to proceed after a patient got the vaccine today and after speaking with the patient they commented that they try and get the vaccine every single year. They did specify that the previous vaccines were administered in 2021, 2022, 2023 and on 27-MAR-2025, which led to extra dose administered. The lot number for the vaccine that was administered in 2021 was PF454, the lot number for the vaccine that was administered on 2022 was NR2X5, the lot number that was administered in 2023 was 9K2MA and the lot number of the vaccine that was administered on March 27th 2025 was 9L944 and the expiration date was March 30th 2027. They did state that they did not have any information about the expiration date for the previous vaccines. The vaccine administration facility was the same as primary reporter.